Ongoing increasing trends in central precocious puberty incidence among Korean boys and girls from 2008 to 2020
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0283510 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Sinyoung Kang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Samil Hospital, Daegu, Korea. Hauptthemen laut MEDLINE: Gonadotropin-Releasing Hormone, Puberty, Precocious. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Over the last few decades, there has been growing evidence of earlier onset and progression of puberty worldwide. This population-based longitudinal cohort study aimed to analyze the change in the annual incidence rate of central precocious puberty (CPP) among Korean children over the most recent decade, using the national registry data.
Method
The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) and insurance claims for gonadotropin-releasing hormone agonist (GnRHa) treatment were used to identify CPP patients who were using the Korean Health Insurance Review & Assessment Service (HIRA) database between 2008 and 2020. Patients who began GnRHa therapy before the age of 9 and 10 for girls and boys, respectively, were included in the study.
Results
A total of 6,906 boys and 126,377 girls were diagnosed with CPP between 2008 and 2020. The annual incidence of CPP increased by 83.3 times in boys (from 1.2 to 100 per 100,000 persons) and by 15.9 times in girls (from 88.9 to 1414.7 per 100,000 persons). The age-specific annual incidence of CPP increased remarkably more in older children than in younger ones; the 2020 CPP incidence among 9-year-old boys and 8-year-old girls reached 705.2 and 7,967.3 per 100,000 persons, respectively. The annual prevalence of CPP in boys and girls increased from 2.7 to 206.5 (76.5 times) and from 141.8 to 3439.9 (24.3 times) per 100,000 persons, respectively.
Conclusion
Based on GnRHa treatment insurance claims, our study suggests that the annual incidence of CPP has substantially increased in Korea during the past 13 years. These findings highlight the importance of meticulous judgment by doctors in determining GnRHa treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Samil Hospital, Daegu, Korea.
- Dr. Park Mijung's Child Growth Clinic, Seoul, Korea.
- Department of Internal Medicine, Inje University Sanggye Paik Hospital, Seoul, Korea.
- Department of Obstetrics and Gynecology, Inje University Sanggye Paik Hospital, Seoul, Korea.
- Department of Pediatrics, Inje University Sanggye Paik Hospital, Seoul, Korea.
ORCID-Profile: Sinyoung Kang, Shin-Hye Kim
Zitieren
APA
Kang, S., Park, M. J., Kim, J. M., Yuk, J. S., & Kim, S. H. (2023). Ongoing increasing trends in central precocious puberty incidence among Korean boys and girls from 2008 to 2020. PLOS ONE. https://doi.org/10.1371/journal.pone.0283510
Vancouver
Kang S, Park MJ, Kim JM, Yuk JS, Kim SH. Ongoing increasing trends in central precocious puberty incidence among Korean boys and girls from 2008 to 2020. PLOS ONE. 2023. doi:10.1371/journal.pone.0283510
BibTeX
@article{Kang2023,
author = {Kang, Sinyoung and Park, Mi Jung and Kim, Jung Min and Yuk, Jin-Sung and Kim, Shin-Hye},
title = {Ongoing increasing trends in central precocious puberty incidence among Korean boys and girls from 2008 to 2020},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0283510}
}
EUVIMED